Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis.

Carr EJ, Niederer HA, Williams J, Harper L, Watts RA, Lyons PA, Smith KG.

BMC Med Genet. 2009 Dec 1;10:121. doi: 10.1186/1471-2350-10-121.

2.

Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families.

Rodríguez A, Alfaro JM, Balthazar V, Pineda Trujillo N.

J Diabetes. 2015 May;7(3):402-10. doi: 10.1111/1753-0407.12192. Epub 2014 Sep 10.

PMID:
25042601
3.

Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.

Moravvej H, Tabatabaei-Panah PS, Abgoon R, Khaksar L, Sokhandan M, Tarshaei S, Ghaderian SMH, Ludwig RJ, Akbarzadeh R.

Immunol Invest. 2018 Oct;47(7):666-679. doi: 10.1080/08820139.2018.1480032. Epub 2018 Jul 6.

PMID:
29979892
4.

Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.

Karlson EW, Chibnik LB, Cui J, Plenge RM, Glass RJ, Maher NE, Parker A, Roubenoff R, Izmailova E, Coblyn JS, Weinblatt ME, Shadick NA.

Ann Rheum Dis. 2008 Mar;67(3):358-63. Epub 2007 Jul 31.

5.

The protein tyrosine phosphatase nonreceptor 22 C1858T polymorphism and vasculitis: a meta-analysis.

Lee YH, Choi SJ, Ji JD, Song GG.

Mol Biol Rep. 2012 Aug;39(8):8505-11. doi: 10.1007/s11033-012-1705-x. Epub 2012 Jun 14.

PMID:
22696186
6.

PTPN22 R620W polymorphism in the ANCA-associated vasculitides.

Martorana D, Maritati F, Malerba G, Bonatti F, Alberici F, Oliva E, Sebastio P, Manenti L, Brugnano R, Catanoso MG, Fraticelli P, Guida G, Gregorini G, Possenti S, Moroni G, Leoni A, Pavone L, Pesci A, Sinico RA, Di Toma L, D'Amico M, Tumiati B, D'Ippolito R, Buzio C, Neri TM, Vaglio A.

Rheumatology (Oxford). 2012 May;51(5):805-12. doi: 10.1093/rheumatology/ker446. Epub 2012 Jan 11.

7.

PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.

LaBerge GS, Bennett DC, Fain PR, Spritz RA.

J Invest Dermatol. 2008 Jul;128(7):1757-62. doi: 10.1038/sj.jid.5701233. Epub 2008 Jan 17.

8.

PTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysis.

Cao Y, Liu K, Tian Z, Hogan SL, Yang J, Poulton CJ, Falk RJ, Li W.

J Rheumatol. 2015 Feb;42(2):292-9. doi: 10.3899/jrheum.131430. Epub 2014 Dec 1.

9.

LADA and T1D in Estonian population - two different genetic risk profiles.

Kisand K, Uibo R.

Gene. 2012 Apr 15;497(2):285-91. doi: 10.1016/j.gene.2012.01.089. Epub 2012 Feb 3.

PMID:
22326526
10.
11.

Associations of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population.

Ke X, Song S, Wang X, Shen Y, Kang H, Hong S.

Hum Immunol. 2017 Feb;78(2):227-231. doi: 10.1016/j.humimm.2016.11.008. Epub 2016 Nov 22.

PMID:
27888068
12.
13.

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium.

Arthritis Rheumatol. 2017 May;69(5):1054-1066. doi: 10.1002/art.40034. Epub 2017 Apr 6.

14.

Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.

Inoue N, Watanabe M, Yamada H, Takemura K, Hayashi F, Yamakawa N, Akahane M, Shimizuishi Y, Hidaka Y, Iwatani Y.

J Clin Immunol. 2012 Dec;32(6):1243-52. doi: 10.1007/s10875-012-9721-0. Epub 2012 Jun 17.

PMID:
22706687
15.

Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4.

Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, Wolfe F, Kastner DL, Alfredsson L, Altshuler D, Gregersen PK, Klareskog L, Rioux JD.

Am J Hum Genet. 2005 Dec;77(6):1044-60. Epub 2005 Nov 1.

16.

Association of PTPN22 rs2476601 and STAT4 rs7574865 polymorphisms with rheumatoid arthritis: A meta-analysis update.

Elshazli R, Settin A.

Immunobiology. 2015 Aug;220(8):1012-24. doi: 10.1016/j.imbio.2015.04.003. Epub 2015 Apr 28.

PMID:
25963842
17.

Association of TNF-α, CTLA4, and PTPN22 polymorphisms with type 1 diabetes and other autoimmune diseases in Brazil.

Tavares NA, Santos MM, Moura R, Araújo J, Guimarães RL, Crovella S, Brandão LA.

Genet Mol Res. 2015 Dec 28;14(4):18936-44. doi: 10.4238/2015.December.28.42.

18.

Genotype analysis of polymorphisms in autoimmune susceptibility genes, CTLA-4 and PTPN22, in an acute anterior uveitis cohort.

Martin TM, Bye L, Modi N, Stanford MR, Vaughan R, Smith JR, Wade NK, Mackensen F, Suhler EB, Rosenbaum JT, Wallace GR.

Mol Vis. 2009;15:208-12. Epub 2009 Jan 26.

19.

Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes.

Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Rønningen KS, Stene LC.

Diabetologia. 2008 Apr;51(4):589-96. doi: 10.1007/s00125-008-0932-0. Epub 2008 Feb 22.

20.

PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus.

Abbasi F, Soltani S, Saghazadeh A, Soltaninejad E, Rezaei A, Zare Bidoki A, Bahrami T, Amirzargar AA, Rezaei N.

Immunol Invest. 2017 May;46(4):409-418. doi: 10.1080/08820139.2017.1288239. Epub 2017 Apr 4.

PMID:
28375784

Supplemental Content

Support Center